• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

针对主要桦树花粉过敏原Bet v I的T细胞克隆与榛树主要过敏原Cor a I和桤木主要过敏原Aln g I发生交叉反应。

T cell clones specific for Bet v I, the major birch pollen allergen, crossreact with the major allergens of hazel, Cor a I, and alder, Aln g I.

作者信息

Ebner C, Ferreira F, Hoffmann K, Hirschwehr R, Schenk S, Szépfalusi Z, Breiteneder H, Parronchi P, Romagnani S, Scheiner O

机构信息

Institute of General and Experimental Pathology, University of Vienna, Austria.

出版信息

Mol Immunol. 1993 Oct;30(15):1323-9. doi: 10.1016/0161-5890(93)90093-q.

DOI:10.1016/0161-5890(93)90093-q
PMID:7694084
Abstract

Tree pollens are responsible for type I allergies during the flowering season in spring. Pollens from birch, hazel and alder constitute the most important allergen sources in this respect in the northern hemisphere. Human IgE antibodies, specific for the major allergens of these pollens, are known to crossreact, and in general every tree pollen allergic patient is sensitized to these three pollen allergens. In this study we investigated eight T-helper cell clones (CD3+, CD4+, TCR alpha/beta) with specificity for Bet v I, the major birch pollen allergen, as proved by reactivity with purified natural as well as with recombinant allergen. The T cell clones were used to investigate common T cell epitopes of the Bet v I molecule with Cor a I, the major allergen of hazel pollen and Aln g I, the major allergen of alder pollen. All eight T cell clones reacted with all three proteins with different intensity. Moreover, three T cell clones, which were known to react with immunodominant T cell epitopes on the Bet v I molecule, were tested for reactivity with dodecapeptides synthesized according to the corresponding homologous regions of the Cor a I and Aln g I sequence. All the peptides induced strong T cell proliferation, indicating the existence of multiple cross-reacting epitopes. These findings will have an impact on the production of vaccines for immunotherapy of tree pollen allergies.

摘要

在春季开花季节,树花粉会引发I型过敏反应。在北半球,桦树、榛树和桤木的花粉是这方面最重要的过敏原来源。已知针对这些花粉主要过敏原的人类IgE抗体存在交叉反应,一般来说,每个对树花粉过敏的患者都会对这三种花粉过敏原敏感。在本研究中,我们调查了八个T辅助细胞克隆(CD3 +、CD4 +、TCRα/β),它们对桦树主要花粉过敏原Bet v I具有特异性,这通过与纯化的天然过敏原以及重组过敏原的反应得以证明。这些T细胞克隆用于研究Bet v I分子与榛树花粉主要过敏原Cor a I和桤木花粉主要过敏原Aln g I的共同T细胞表位。所有八个T细胞克隆都以不同强度与这三种蛋白质发生反应。此外,测试了三个已知与Bet v I分子上免疫显性T细胞表位发生反应的T细胞克隆与根据Cor a I和Aln g I序列相应同源区域合成的十二肽的反应性。所有这些肽都诱导了强烈的T细胞增殖,表明存在多个交叉反应表位。这些发现将对树花粉过敏免疫治疗疫苗的生产产生影响。

相似文献

1
T cell clones specific for Bet v I, the major birch pollen allergen, crossreact with the major allergens of hazel, Cor a I, and alder, Aln g I.针对主要桦树花粉过敏原Bet v I的T细胞克隆与榛树主要过敏原Cor a I和桤木主要过敏原Aln g I发生交叉反应。
Mol Immunol. 1993 Oct;30(15):1323-9. doi: 10.1016/0161-5890(93)90093-q.
2
Characterization of the T cell response to the major hazelnut allergen, Cor a 1.04: evidence for a relevant T cell epitope not cross-reactive with homologous pollen allergens.对主要榛子过敏原Cor a 1.04的T细胞反应特性:存在与同源花粉过敏原无交叉反应的相关T细胞表位的证据。
Clin Exp Allergy. 2005 Oct;35(10):1392-9. doi: 10.1111/j.1365-2222.2005.02332.x.
3
Four recombinant isoforms of Cor a 1, the major allergen of hazel pollen, show different reactivities with allergen-specific T-lymphocyte clones.榛树花粉的主要过敏原Cor a 1的四种重组亚型与过敏原特异性T淋巴细胞克隆表现出不同的反应性。
Eur J Biochem. 1994 Sep 1;224(2):717-22. doi: 10.1111/j.1432-1033.1994.00717.x.
4
Identification of multiple T cell epitopes on Bet v I, the major birch pollen allergen, using specific T cell clones and overlapping peptides.利用特异性T细胞克隆和重叠肽鉴定主要桦树花粉过敏原Bet v I上的多个T细胞表位。
J Immunol. 1993 Feb 1;150(3):1047-54.
5
T cells specific to multiple Bet v 1 peptides are highly cross-reactive toward the corresponding peptides from the homologous group of tree pollens.T 细胞针对多个 Bet v 1 肽具有高度的交叉反应性,针对来自同源花粉组的相应肽。
Front Immunol. 2023 Nov 22;14:1291666. doi: 10.3389/fimmu.2023.1291666. eCollection 2023.
6
Bet v 1, the major birch pollen allergen, and Mal d 1, the major apple allergen, cross-react at the level of allergen-specific T helper cells.主要桦树花粉过敏原Bet v 1和主要苹果过敏原Mal d 1在过敏原特异性辅助性T细胞水平上发生交叉反应。
J Allergy Clin Immunol. 1998 Oct;102(4 Pt 1):679-86. doi: 10.1016/s0091-6749(98)70287-8.
7
Four recombinant isoforms of Cor a I, the major allergen of hazel pollen, show different IgE-binding properties.榛树花粉的主要过敏原Cor a I的四种重组亚型表现出不同的IgE结合特性。
Eur J Biochem. 1993 Mar 1;212(2):355-62. doi: 10.1111/j.1432-1033.1993.tb17669.x.
8
Recombinant birch pollen allergens (rBet v 1 and rBet v 2) contain most of the IgE epitopes present in birch, alder, hornbeam, hazel, and oak pollen: a quantitative IgE inhibition study with sera from different populations.重组桦树花粉过敏原(rBet v 1和rBet v 2)包含桦树、桤木、鹅耳枥、榛树和橡树花粉中存在的大部分IgE表位:一项针对不同人群血清的IgE定量抑制研究。
J Allergy Clin Immunol. 1998 Oct;102(4 Pt 1):579-91. doi: 10.1016/s0091-6749(98)70273-8.
9
Bet v 1-independent sensitization to major allergens in Fagales pollen: Evidence at the T-cell level.山龙眼科花粉主要过敏原特异性致敏不受 Bet v 1 影响:T 细胞水平的证据。
Allergy. 2023 Mar;78(3):743-751. doi: 10.1111/all.15594. Epub 2022 Dec 8.
10
How far can we simplify in vitro diagnostics for Fagales tree pollen allergy? A study with three whole pollen extracts and purified natural and recombinant allergens.我们能在多大程度上简化壳斗目树花粉过敏的体外诊断?一项针对三种全花粉提取物以及纯化的天然和重组过敏原的研究。
Clin Exp Allergy. 1999 Jun;29(6):848-55. doi: 10.1046/j.1365-2222.1999.00521.x.

引用本文的文献

1
T cells specific to multiple Bet v 1 peptides are highly cross-reactive toward the corresponding peptides from the homologous group of tree pollens.T 细胞针对多个 Bet v 1 肽具有高度的交叉反应性,针对来自同源花粉组的相应肽。
Front Immunol. 2023 Nov 22;14:1291666. doi: 10.3389/fimmu.2023.1291666. eCollection 2023.
2
Bet v 1-independent sensitization to major allergens in Fagales pollen: Evidence at the T-cell level.山龙眼科花粉主要过敏原特异性致敏不受 Bet v 1 影响:T 细胞水平的证据。
Allergy. 2023 Mar;78(3):743-751. doi: 10.1111/all.15594. Epub 2022 Dec 8.
3
Identification of apple cultivars hypoallergenic for birch pollen-allergic individuals by a multidisciplinary in vitro and in vivo approach.
通过多学科的体外和体内方法鉴定对桦树花粉过敏个体低致敏性的苹果品种。
Clin Transl Allergy. 2022 Aug;12(8):e12186. doi: 10.1002/clt2.12186.
4
How Do Pollen Allergens Sensitize?花粉过敏原是如何致敏的?
Front Mol Biosci. 2022 Jun 16;9:900533. doi: 10.3389/fmolb.2022.900533. eCollection 2022.
5
Simplified AIT for allergy to several tree pollens-Arguments from the immune outcome analyses following treatment with SQ tree SLIT-tablet.简化变应原免疫治疗(AIT)用于治疗多种花粉过敏症的免疫结果分析-来自 SQ 树 SLIT 舌下片剂治疗后的分析。
Clin Exp Allergy. 2021 Feb;51(2):284-295. doi: 10.1111/cea.13788. Epub 2020 Dec 8.
6
Alder pollen concentrations in the air during snowfall.降雪时空气中的桤木花粉浓度。
Int J Biometeorol. 2019 Dec;63(12):1651-1658. doi: 10.1007/s00484-019-01781-3. Epub 2019 Sep 6.
7
Allergen hybrids - next generation vaccines for Fagales pollen immunotherapy.变应原杂交体 - 壳斗科花粉免疫治疗的下一代疫苗。
Clin Exp Allergy. 2014 Mar;44(3):438-49. doi: 10.1111/cea.12250.
8
Aerial pollen diversity in India and their clinical significance in allergic diseases.印度的气传花粉多样性及其在过敏性疾病中的临床意义。
Indian J Clin Biochem. 2004 Jul;19(2):190-201. doi: 10.1007/BF02894284.
9
Differentiation stage determines pathologic and protective allergen-specific CD4+ T-cell outcomes during specific immunotherapy.分化阶段决定了特异性免疫治疗期间变应原特异性 CD4+T 细胞的病理和保护结局。
J Allergy Clin Immunol. 2012 Feb;129(2):544-51, 551.e1-7. doi: 10.1016/j.jaci.2011.08.034. Epub 2011 Oct 5.
10
Allergenic crossreactivities. Pollens and vegetable foods.变应原交叉反应性。花粉与植物性食物。
Clin Rev Allergy Immunol. 1997 Winter;15(4):397-404. doi: 10.1007/BF02737735.